_id
6915fbe5bc934aba376b275b
Ticker
SNNAQ
Name
Sienna Biopharmaceuticals Inc
Exchange
PINK
Address
30699 Russell Ranch Road, Westlake Village, CA, United States, 91362
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.siennabio.com
Description
Sienna Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs in various therapeutic areas. It develops therapies in immunology and inflammation that target select pathways in tissues, such as skin. The company's lead product candidates include SNA-120, a first-in-class inhibitor of tropomyosin receptor kinase A, which is in a Phase IIb clinical trial for the treatment of psoriasis and associated pruritus; and SNA-125, a topical dual Janus kinase 3 inhibitor that is in Phase I/II clinical trials for the treatment of atopic dermatitis, psoriasis, and pruritus. It also develops SNA-001, a topical suspension of silver particles, which is in pivotal clinical trials for the treatment of acne, as well as for the reduction of light-pigmented hair, including white, gray, blonde, light brown, and light red hair. The company was formerly known as Sienna Labs, Inc. and changed its name to Sienna Biopharmaceuticals, Inc. in February 2016. Sienna Biopharmaceuticals, Inc. was founded in 2010 and is headquartered in Westlake Village, California. On December 18, 2019, Sienna Biopharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 16, 2019.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-07T12:05:16.921Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
3090
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2019-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
8841000
Operating Income
-6036000
Interest Expense
1055000
Pretax Income
-8588000
Net Income
-3970000
Eps
-0.12920653518193062
Dividends Per Share
-
Shares Outstanding
30907542
Income Tax Expense
-4618000
EBITDA
-8805000
Operating Margin
-
Total Other Income Expense Net
253000
Cash
11332000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
19731000
Property Plant Equipment
261000
Total Assets
43492000
Payables
187000
Short Term Debt
-
Long Term Debt
10103000
Total Liabilities
20391000
Equity
23101000
Bs_currency_symbol
USD
Depreciation
36000
Change In Working Capital
-8279000
Cash From Operations
-17844000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-20000000
Net Change In Cash
-37843000
Cf_currency_symbol
USD
PE
-
PB
0.00013300722912428035
ROE
-17.18540322929743
ROA
-9.128115515497102
FCF
-17844000
Fcf Percent
-
Piotroski FScore
0
Health Score
37
Deep Value Investing Score
5.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
3.5
Quality Investing Score
2
Value Investing Score
6
Quarters > 0 > quarter
2019-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
8841000
Quarters > 0 > income Statement > operating Income
-6036000
Quarters > 0 > income Statement > interest Expense
1055000
Quarters > 0 > income Statement > pretax Income
-8588000
Quarters > 0 > income Statement > net Income
-3970000
Quarters > 0 > income Statement > eps
-0.12920653518193062
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
30726000
Quarters > 0 > income Statement > income Tax Expense
-4618000
Quarters > 0 > income Statement > EBITDA
-8805000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
253000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
11332000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
19731000
Quarters > 0 > balance Sheet > property Plant Equipment
261000
Quarters > 0 > balance Sheet > total Assets
43492000
Quarters > 0 > balance Sheet > payables
187000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
10103000
Quarters > 0 > balance Sheet > total Liabilities
20391000
Quarters > 0 > balance Sheet > equity
23101000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3970000
Quarters > 0 > cash Flow > depreciation
36000
Quarters > 0 > cash Flow > change In Working Capital
-8279000
Quarters > 0 > cash Flow > cash From Operations
-17844000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-20000000
Quarters > 0 > cash Flow > net Change In Cash
-37843000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.12920653518193062
Quarters > 0 > ratios > PB
0.00013300722912428035
Quarters > 0 > ratios > ROE
-17.18540322929743
Quarters > 0 > ratios > ROA
-9.128115515497102
Quarters > 0 > ratios > FCF
-17844000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2019-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
7727000
Quarters > 1 > income Statement > operating Income
-7727000
Quarters > 1 > income Statement > interest Expense
800000
Quarters > 1 > income Statement > pretax Income
-8264000
Quarters > 1 > income Statement > net Income
-8264000
Quarters > 1 > income Statement > eps
-0.27225406865651974
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
30354000
Quarters > 1 > income Statement > income Tax Expense
537000
Quarters > 1 > income Statement > EBITDA
-7690000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-537000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
49207000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
50617000
Quarters > 1 > balance Sheet > property Plant Equipment
949000
Quarters > 1 > balance Sheet > total Assets
107625000
Quarters > 1 > balance Sheet > payables
1522000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
29474000
Quarters > 1 > balance Sheet > total Liabilities
80642000
Quarters > 1 > balance Sheet > equity
26983000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-8264000
Quarters > 1 > cash Flow > depreciation
37000
Quarters > 1 > cash Flow > change In Working Capital
-1213000
Quarters > 1 > cash Flow > cash From Operations
-8417000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
452000
Quarters > 1 > cash Flow > net Change In Cash
-7962000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.27225406865651974
Quarters > 1 > ratios > PB
0.00011249305118037284
Quarters > 1 > ratios > ROE
-30.626690879442613
Quarters > 1 > ratios > ROA
-7.678513356562138
Quarters > 1 > ratios > FCF
-8417000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
27
Quarters > 2 > quarter
2019-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
15839000
Quarters > 2 > income Statement > operating Income
-15839000
Quarters > 2 > income Statement > interest Expense
800000
Quarters > 2 > income Statement > pretax Income
-16382000
Quarters > 2 > income Statement > net Income
-16382000
Quarters > 2 > income Statement > eps
-0.6657725757945216
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
24606000
Quarters > 2 > income Statement > income Tax Expense
543000
Quarters > 2 > income Statement > EBITDA
-15800000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-543000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
57169000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
58669000
Quarters > 2 > balance Sheet > property Plant Equipment
1047000
Quarters > 2 > balance Sheet > total Assets
115054000
Quarters > 2 > balance Sheet > payables
2180000
Quarters > 2 > balance Sheet > short Term Debt
300000
Quarters > 2 > balance Sheet > long Term Debt
29237000
Quarters > 2 > balance Sheet > total Liabilities
81768000
Quarters > 2 > balance Sheet > equity
33286000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-16382000
Quarters > 2 > cash Flow > depreciation
39000
Quarters > 2 > cash Flow > change In Working Capital
-3020000
Quarters > 2 > cash Flow > cash From Operations
-12769000
Quarters > 2 > cash Flow > capital Expenditures
4000
Quarters > 2 > cash Flow > cash From Investing
-4000
Quarters > 2 > cash Flow > cash From Financing
21426000
Quarters > 2 > cash Flow > net Change In Cash
8643000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.6657725757945216
Quarters > 2 > ratios > PB
0.00007392297061827796
Quarters > 2 > ratios > ROE
-49.21588655891366
Quarters > 2 > ratios > ROA
-14.23853147217828
Quarters > 2 > ratios > FCF
-12773000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
28
Quarters > 3 > quarter
2018-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
19769000
Quarters > 3 > income Statement > operating Income
-19769000
Quarters > 3 > income Statement > interest Expense
800000
Quarters > 3 > income Statement > pretax Income
-19335000
Quarters > 3 > income Statement > net Income
-19295000
Quarters > 3 > income Statement > eps
-0.9274212929584235
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
20805000
Quarters > 3 > income Statement > income Tax Expense
-40000
Quarters > 3 > income Statement > EBITDA
-19729000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
434000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
48526000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
50412000
Quarters > 3 > balance Sheet > property Plant Equipment
311000
Quarters > 3 > balance Sheet > total Assets
107306000
Quarters > 3 > balance Sheet > payables
2792000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
30125000
Quarters > 3 > balance Sheet > total Liabilities
80725000
Quarters > 3 > balance Sheet > equity
159368000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-19335000
Quarters > 3 > cash Flow > depreciation
40000
Quarters > 3 > cash Flow > change In Working Capital
-1903000
Quarters > 3 > cash Flow > cash From Operations
-15599000
Quarters > 3 > cash Flow > capital Expenditures
6000
Quarters > 3 > cash Flow > cash From Investing
-6000
Quarters > 3 > cash Flow > cash From Financing
293000
Quarters > 3 > cash Flow > net Change In Cash
-15449000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.9274212929584235
Quarters > 3 > ratios > PB
0.000013054691029566789
Quarters > 3 > ratios > ROE
-12.107198433813563
Quarters > 3 > ratios > ROA
-17.981287160084243
Quarters > 3 > ratios > FCF
-15605000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-
Annuals > 0 > income Statement > net Income
-
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
30726000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
-
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
-
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-
Annuals > 0 > cash Flow > depreciation
228485
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
-
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
45
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
-
Annuals > 1 > income Statement > operating Income
-
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-
Annuals > 1 > income Statement > net Income
-
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
30726000
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
-
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
-
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
-
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
-
Annuals > 1 > balance Sheet > equity
-
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-
Annuals > 1 > cash Flow > depreciation
236558
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-
Annuals > 1 > cash Flow > capital Expenditures
-
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-
Annuals > 1 > ratios > ROA
-
Annuals > 1 > ratios > FCF
-
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
45
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
-
Annuals > 2 > income Statement > operating Income
-
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-
Annuals > 2 > income Statement > net Income
-
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
30726000
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
-
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
-
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
-
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
-
Annuals > 2 > balance Sheet > equity
-
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-
Annuals > 2 > cash Flow > depreciation
206297
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-
Annuals > 2 > cash Flow > capital Expenditures
-
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-
Annuals > 2 > ratios > ROA
-
Annuals > 2 > ratios > FCF
-
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
45
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
-
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-
Annuals > 3 > income Statement > net Income
-
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
30726000
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
-
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
-
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
-
Annuals > 3 > balance Sheet > equity
-
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-
Annuals > 3 > cash Flow > depreciation
171860
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
-
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
-
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
45
Valuation > metrics > PE
-0.12920653518193062
Valuation > metrics > PB
0.00013300722912428035
Valuation > final Score
70
Valuation > verdict
100.0% Undervalued
Profitability > metrics > ROE
-17.18540322929743
Profitability > metrics > ROA
-20.120622370888448
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.882689061079607
Risk > metrics > Interest Coverage
-5.7213270142180095
Risk > final Score
25
Risk > verdict
High
Liquidity > metrics > Current Ratio
105.51336898395722
Liquidity > metrics > Quick Ratio
105.51336898395722
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-21
Prev Risks > 1
-61
Prev Risks > 2
-51
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:35:59.428Z
Earnings History > 0 > period
2022-06-30
Earnings History > 0 > report Date
2022-08-31
Earnings History > 0 > date
2022-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2022-03-31
Earnings History > 1 > report Date
2022-05-12
Earnings History > 1 > date
2022-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2021-12-31
Earnings History > 2 > report Date
2022-03-17
Earnings History > 2 > date
2021-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2021-09-30
Earnings History > 3 > report Date
2021-11-11
Earnings History > 3 > date
2021-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-06-30
Earnings History > 4 > report Date
2021-09-09
Earnings History > 4 > date
2021-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-03-31
Earnings History > 5 > report Date
2021-05-17
Earnings History > 5 > date
2021-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-12-31
Earnings History > 6 > report Date
2021-03-18
Earnings History > 6 > date
2020-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-09-30
Earnings History > 7 > report Date
2020-10-09
Earnings History > 7 > date
2020-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-03-31
Earnings History > 8 > report Date
2020-05-18
Earnings History > 8 > date
2020-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-12-31
Earnings History > 9 > report Date
2020-03-12
Earnings History > 9 > date
2019-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
-0.22
Earnings History > 9 > eps Difference
0.22
Earnings History > 9 > surprise Percent
100
Earnings History > 10 > period
2019-09-30
Earnings History > 10 > report Date
2019-11-12
Earnings History > 10 > date
2019-09-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.13
Earnings History > 10 > eps Estimate
-0.24
Earnings History > 10 > eps Difference
0.11
Earnings History > 10 > surprise Percent
45.8333
Earnings History > 11 > period
2019-06-30
Earnings History > 11 > report Date
2019-08-08
Earnings History > 11 > date
2019-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.27
Earnings History > 11 > eps Estimate
-0.4
Earnings History > 11 > eps Difference
0.13
Earnings History > 11 > surprise Percent
32.5
Earnings History > 12 > period
2019-03-31
Earnings History > 12 > report Date
2019-05-08
Earnings History > 12 > date
2019-03-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.63
Earnings History > 12 > eps Estimate
-0.5
Earnings History > 12 > eps Difference
-0.13
Earnings History > 12 > surprise Percent
-26
Earnings History > 13 > period
2018-12-31
Earnings History > 13 > report Date
2019-03-14
Earnings History > 13 > date
2018-12-31
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.93
Earnings History > 13 > eps Estimate
-0.83
Earnings History > 13 > eps Difference
-0.1
Earnings History > 13 > surprise Percent
-12.0482
Earnings History > 14 > period
2018-09-30
Earnings History > 14 > report Date
2018-11-08
Earnings History > 14 > date
2018-09-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.82
Earnings History > 14 > eps Estimate
-0.79
Earnings History > 14 > eps Difference
-0.03
Earnings History > 14 > surprise Percent
-3.7975
Earnings History > 15 > period
2018-06-30
Earnings History > 15 > report Date
2018-08-09
Earnings History > 15 > date
2018-06-30
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-1
Earnings History > 15 > eps Estimate
-0.79
Earnings History > 15 > eps Difference
-0.21
Earnings History > 15 > surprise Percent
-26.5823
Earnings History > 16 > period
2018-03-31
Earnings History > 16 > report Date
2018-05-14
Earnings History > 16 > date
2018-03-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.85
Earnings History > 16 > eps Estimate
-0.71
Earnings History > 16 > eps Difference
-0.14
Earnings History > 16 > surprise Percent
-19.7183
Earnings History > 17 > period
2017-12-31
Earnings History > 17 > report Date
2018-03-15
Earnings History > 17 > date
2017-12-31
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.56
Earnings History > 17 > eps Estimate
-0.79
Earnings History > 17 > eps Difference
0.23
Earnings History > 17 > surprise Percent
29.1139
Earnings History > 18 > period
2017-09-30
Earnings History > 18 > report Date
2017-11-09
Earnings History > 18 > date
2017-09-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-1.12
Earnings History > 18 > eps Estimate
-0.69
Earnings History > 18 > eps Difference
-0.43
Earnings History > 18 > surprise Percent
-62.3188
Earnings History > 19 > period
2017-06-30
Earnings History > 19 > report Date
2017-09-07
Earnings History > 19 > date
2017-06-30
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.63
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2017-03-31
Earnings History > 20 > report Date
2017-05-31
Earnings History > 20 > date
2017-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.66
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.66
Earnings History > 20 > surprise Percent
-
Sienna Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs in various therapeutic areas. It develops therapies in immunology and inflammation that target select pathways in tissues, such as skin. The company's lead product candidates include SNA-120, a first-in-class inhibitor of tropomyosin receptor kinase A, which is in a Phase IIb clinical trial for the treatment of psoriasis and associated pruritus; and SNA-125, a topical dual Janus kinase 3 inhibitor that is in Phase I/II clinical trials for the treatment of atopic dermatitis, psoriasis, and pruritus. It also develops SNA-001, a topical suspension of silver particles, which is in pivotal clinical trials for the treatment of acne, as well as for the reduction of light-pigmented hair, including white, gray, blonde, light brown, and light red hair. The company was formerly known as Sienna Labs, Inc. and changed its name to Sienna Biopharmaceuticals, Inc. in February 2016. Sienna Biopharmaceuticals, Inc. was founded in 2010 and is headquartered in Westlake Village, California. On December 18, 2019, Sienna Biopharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 16, 2019.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2019-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Sienna Biopharmaceuticals Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2022-06-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2019-09-30)
(Last Updated 2019-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2019-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2019-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.